|
| |
COMPOSITION
: |
| |
|
|
|
| |
Each ml. of
|
| |
|
|
|
| |
SPECTRO
ENF Contains : |
| |
|
|
|
| |
Enrofloxacin
.............................................................. |
100 mg |
| |
INDICATION
: |
| |
|
|
|
| |
|
CRD ( Chronic Respiratory
Disease) |
|
| |
|
|
| |
|
Broncho Pneumonia |
| |
|
|
| |
|
Cholera |
| |
|
|
| |
|
Typhoid |
| |
|
|
| |
|
Paratyphoid |
| |
|
|
| |
|
Colibacillosis |
| |
|
|
| |
|
Colisepticaemia etc.. |
| |
CHARACTERISTICS
: |
| |
|
| |
SPECTRO
ENF is useful for the prevention & Treatment of
CRD
(Chronic Respiratory Disease) complex, due to Mycoplasma spp. Infection |
| |
|
| |
SPECTRO
ENF is effective against common poultry pathogens
like Salmonella, E.colli, and Pasteurella |
| |
|
| |
SPECTRO
ENF does not have any side effect after oral administration
at therapeutic dose rates |
| |
|
| |
SPECTRO
ENF does not have any Immunosuppressive effect |
| |
|
| |
DOSAGE
: |
| |
|
| |
1 ml / 2 ltrs of drinking
water for 5 days |
| |
PRESENTATION |
| |
|
| |
1 ltr. HDPE Bottle x 10
in Shipper |
| |
|
| |
25 ltr. Drum |
| |
|
If
interested in this product, Please  |
| |
*
PRODUCT IS AVAILABLE SUBJECT TO PATENT LAW OF BUYER’S
COUNTRY |
|
 |